Global Expansion QPS Netherlands is part of a growing North American expansion with new US offices and facility growth signaling a pivot to multi-region clinical programs; this creates cross-border trial opportunities for sponsors in North America seeking local CRO support, faster site activation, and regulatory-aligned operations.

AI Collaboration Strategic collaboration with AI partners shows a commitment to optimizing trial design and execution; there is an opportunity to position QPS as a partner for AI-enabled data analytics, real-time risk monitoring, and automation in data management, biometrics, and medical writing.

Cell Therapy Lead The Leukopak and Cell Therapy facility and leadership hiring indicate a focus on advanced therapies; this opens doors to sponsors in cell therapy and regenerative medicine needing specialized manufacturing support, packaging, QC, and supply chain capabilities.

Full Trial Coverage The Netherlands unit operates across early to late-stage trials with a dedicated clinical pharmacology unit, enabling end-to-end trial execution and robust data capabilities; this can be pitched to sponsors seeking a single CRO to manage complex multinational studies with integrated labs and bioanalysis.

Global CRO Network As part of a global CRO group with investments in labs, staffing, and bioanalytical capacity, QPS offers cross-sell opportunities to existing and new clients across regions, including expansion-ready service bundles in data management, biometrics, bioanalysis, and temporary staffing to support peak trial demand.